Stock listing
NOVN Stock Price, News, Filings & Events — Novartis Ag
Selected listing: NOVN · SIX · CHF · CH
This page tracks Novartis Ag's NOVN:SIX listing on SIX in CHF for CH, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following NOVN:SIX. NOVN:SIX is the stock-level entry point for investors researching Novartis Ag, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Novartis AG is a public company based in Switzerland, trading under the ticker NOVN. With a market capitalization of approximately 285.26 billion Swiss francs, Novartis is a leading global healthcare company focused on innovative pharmaceuticals and advanced therapies. The company is committed to improving patient outcomes through research and development in various therapeutic areas.
- Ticker
- NOVN:SIX
- Asset type
- Stock
- Market cap
- $288.81B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- SIX
- Currency
- CHF
Novartis Ag NOVN:SIX stock context
This page tracks Novartis Ag's NOVN:SIX listing on SIX in CHF for CH, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following NOVN:SIX. NOVN:SIX is the stock-level entry point for investors researching Novartis Ag, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Novartis AG is a public company based in Switzerland, trading under the ticker NOVN. With a market capitalization of approximately 285.26 billion Swiss francs, Novartis is a leading global healthcare company focused on innovative pharmaceuticals and advanced therapies. The company is committed to improving patient outcomes through research and development in various therapeutic areas.
Latest news from Novartis Ag
Novartis receives Health Canada approval for (Pr)RHAPSIDO® (remibrutinib tablets) oral treatment for adults with CSU
July 27, 2026
Novartis Fabhalta® (iptacopan) receives FDA traditional approval as first and only complement inhibitor to significantly slow kidney func...
July 16, 2026
Sofinnova Partners Announces Myricx Bio Agrees to Be Acquired by Novartis
July 6, 2026
Brandon Capital Announces Agreement for Novartis to Acquire Portfolio Company Myricx Bio to Advance New Class of Cancer Therapeutics
July 6, 2026
Novartis agrees to acquire Myricx Bio, advancing next-generation antibody-drug conjugate innovation with a novel NMTi payload, expanding ...
July 6, 2026
Novartis Ag earnings calls
Novartis AG (NVS) Q2 2026 Earnings Call
July 21, 2026 · Replay with transcript and chapters
Novartis AG (NVS) Q1 2026 Earnings Call
April 28, 2026 · Replay with transcript and chapters
Novartis AG (NVS) Q4 2025 Earnings Call
February 4, 2026 · Replay with transcript and chapters
Novartis AG (NVS) Q3 2025 Earnings Call
October 28, 2025 · Replay with transcript and chapters
Novartis AG (NVS) Q2 2025 Earnings Call
July 17, 2025 · Replay with transcript and chapters
Novartis AG (NVS) Q1 2025 Earnings Call
April 29, 2025 · Replay with transcript and chapters
Research Novartis Ag
Novartis Ag investor report
Review AI stock analysis and investor report context for NOVN:SIX.
Novartis Ag company profile
View the public company page for Novartis Ag on 6ix.
Novartis Ag news
Read company news and market updates connected to Novartis Ag.
Novartis Ag investor events
Find investor webinars, events, and replay context for Novartis Ag.
Alternate listings
NVS:NYSE
US · USD
Alternate listing for Novartis Ag; the primary context on this page is NOVN:SIX.
NOT:XETR
DE · EUR
Alternate listing for Novartis Ag; the primary context on this page is NOVN:SIX.
NOT:GETTEX
DE · EUR
Alternate listing for Novartis Ag; the primary context on this page is NOVN:SIX.
NVSEF:OTC
US · USD
Alternate listing for Novartis Ag; the primary context on this page is NOVN:SIX.
NOT:TRADEGATE
DE · EUR
Alternate listing for Novartis Ag; the primary context on this page is NOVN:SIX.
1NOVN:MIL
IT · EUR
Alternate listing for Novartis Ag; the primary context on this page is NOVN:SIX.
NVS:BCBA
AR · ARS
Alternate listing for Novartis Ag; the primary context on this page is NOVN:SIX.
0QLR:LSIN
GB · CHF
Alternate listing for Novartis Ag; the primary context on this page is NOVN:SIX.
NOTA:GETTEX
DE · EUR
Alternate listing for Novartis Ag; the primary context on this page is NOVN:SIX.
904278:LSX
DE · EUR
Alternate listing for Novartis Ag; the primary context on this page is NOVN:SIX.
NOVNEE:SIX
CH · CHF
Alternate listing for Novartis Ag; the primary context on this page is NOVN:SIX.
NOT:BX
CH · CHF
Alternate listing for Novartis Ag; the primary context on this page is NOVN:SIX.